Identification of APC Mutation as a Potential Predictor for Immunotherapy in Colorectal Cancer

Figure 3

Survival analysis in the groups with or without APC mutations from public cohorts. (a) TCGA-CRC cohort. (b) MSKCC pancancer immunotherapy cohort. (c) MSKCC-CRC immunotherapy cohort.

(a)

(b)

(c)